578 related articles for article (PubMed ID: 15381144)
21. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
Wong F; Pantea L; Sniderman K
Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
[TBL] [Abstract][Full Text] [Related]
22. [Hepatorenal syndrome].
Mijac D; Kezić A; Stojimirović B
Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
[TBL] [Abstract][Full Text] [Related]
23. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.
Fagundes C; Ginès P
Am J Kidney Dis; 2012 Jun; 59(6):874-85. PubMed ID: 22480795
[TBL] [Abstract][Full Text] [Related]
24. [Hepatorenal syndrome].
Pillebout E
Nephrol Ther; 2014 Feb; 10(1):61-8. PubMed ID: 24388293
[TBL] [Abstract][Full Text] [Related]
25. Hepatorenal syndrome.
Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
[TBL] [Abstract][Full Text] [Related]
26. Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies.
Meltzer J; Brentjens TE
Curr Opin Anaesthesiol; 2010 Apr; 23(2):139-44. PubMed ID: 20124895
[TBL] [Abstract][Full Text] [Related]
27. Terlipressin in hepatorenal syndrome: Evidence for present indications.
Rajekar H; Chawla Y
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
[TBL] [Abstract][Full Text] [Related]
28. Hepatorenal syndrome: do the vasoconstrictors work?
Leung W; Wong F
Gastroenterol Clin North Am; 2011 Sep; 40(3):581-98. PubMed ID: 21893275
[TBL] [Abstract][Full Text] [Related]
29. [Hepatorenal syndrome].
Huschak G; Kaisers UX; Laudi S
Anaesthesist; 2013 Jul; 62(7):571-82. PubMed ID: 23846211
[TBL] [Abstract][Full Text] [Related]
30. [Therapy of hepatorenal syndrome].
Walter E
Praxis (Bern 1994); 1997 Jan; 86(4):102-3. PubMed ID: 9064719
[TBL] [Abstract][Full Text] [Related]
31. Acute kidney injury and hepatorenal syndrome in cirrhosis.
Egerod Israelsen M; Gluud LL; Krag A
J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in hepatorenal syndrome.
Arroyo V; Torre A; Guevara M
Trop Gastroenterol; 2005; 26(1):13-20. PubMed ID: 15974232
[TBL] [Abstract][Full Text] [Related]
33. [Hepatorenal syndrome: diagnosis, treatment and prevention].
Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
[TBL] [Abstract][Full Text] [Related]
34. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
Arroyo V; Terra C; Ginès P
J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
[No Abstract] [Full Text] [Related]
35. [Hepatorenal syndrome].
Bosma JW; van Meyel JJ; Siegert CE
Ned Tijdschr Geneeskd; 2010; 154():A1355. PubMed ID: 20456764
[No Abstract] [Full Text] [Related]
36. [Hepatorenal syndrome: pathogenesis and treatment].
Ashkenazi E; Ilan Y; Shoval D
Harefuah; 2007 Jun; 146(6):475-9, 499. PubMed ID: 17760404
[TBL] [Abstract][Full Text] [Related]
37. Review article: pharmacological treatment of hepatorenal syndrome.
Ginès P; Torre A; Terra C; Guevara M
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():57-62; discussion 63-4. PubMed ID: 15335404
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.
Møller S; Bendtsen F; Henriksen JH
Scand J Gastroenterol; 2005 May; 40(5):491-500. PubMed ID: 16036500
[TBL] [Abstract][Full Text] [Related]
39. New challenge of hepatorenal syndrome: prevention and treatment.
Wong F; Blendis L
Hepatology; 2001 Dec; 34(6):1242-51. PubMed ID: 11732014
[TBL] [Abstract][Full Text] [Related]
40. Hepatorenal syndrome.
Bataller R; Ginès P; Arroyo V; Rodés J
Clin Liver Dis; 2000 May; 4(2):487-507. PubMed ID: 11232202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
